First Tracks Biotherapeutics Inc (TRAX)
$45.08 -0.32% Close Oct 30, 2026 Live
First Tracks Biotherapeutics stock today
First Tracks Biotherapeutics closed at $45.08 on October 30, 2026, down 0.32% on the day. Its market value is $1.57 billion.
$20.00$30.00$40.00
MayJunJulAugSepOct
| Period | TRAX | S&P 500 (SPY) |
|---|---|---|
| 1 month | +27.2% | -0.9% |
| 3 months | -5.7% | +2.1% |
Key statistics
- Market value
- $1.57B
- 52-week range
- $15.32 to $47.92
- Next report
- Nov 5, 2026 (estimated)
About First Tracks Biotherapeutics
Develops gene therapy and cellular therapy treatments for genetic disorders.
Sector: Health Care
No forecast, no recommendation. This page describes First Tracks Biotherapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.